(Q40912652)

24 September 2017

title

ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses (English)

1 reference

24 September 2017

author

Hans-Willi Mittrücker

11

object named as

Hans-Willi Mittrücker

0 references

Valéa Schumacher

5

object named as

Valéa Schumacher

0 references

Stefan Rose-John

object named as

Stefan Rose-John

10

0 references

author name string

Isabell Yan

1

1 reference

24 September 2017

Jeanette Schwarz

2

1 reference

24 September 2017

Karsten Lücke

3

1 reference

24 September 2017

Neele Schumacher

4

1 reference

24 September 2017

Valéa Schumacher

5

1 reference

24 September 2017

Stefanie Schmidt

6

1 reference

24 September 2017

Björn Rabe

7

1 reference

24 September 2017

Paul Saftig

8

1 reference

24 September 2017

Marjo Donners

9

1 reference

24 September 2017

Hans-Willi Mittrücker

11

1 reference

24 September 2017

Athena Chalaris

12

1 reference

24 September 2017

publication date

11 November 2015

1 reference

Journal of Leukocyte Biology

24 September 2017

published in

1 reference

24 September 2017

volume

99

1 reference

24 September 2017

issue

5

1 reference

24 September 2017

page(s)

749-760

1 reference

Metalloproteinases and their natural inhibitors in inflammation and immunity.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

ADAM17: a molecular switch to control inflammation and tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Caspase-1: is IL-1 just the tip of the ICEberg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Interleukin-6 and its receptors: a highly regulated and dynamic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

The IL-6/sIL-6R complex as a novel target for therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model*

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

IL-6 controls the innate immune response against Listeria monocytogenes via classical IL-6 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

The soluble interleukin-6 receptor is generated by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Species specificity of ADAM10 and ADAM17 proteins in interleukin-6 (IL-6) trans-signaling and novel role of ADAM10 in inducible IL-6 receptor shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

ADAMs 10 and 17 represent differentially regulated components of a general shedding machinery for membrane proteins such as transforming growth factor alpha, L-selectin, and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Dynasore, a cell-permeable inhibitor of dynamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

IL-6 biology: implications for clinical targeting in rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Hitting a complex target: an update on interleukin-6 trans-signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Transgenic blockade of interleukin 6 transsignaling abrogates inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Sleep enhances IL-6 trans-signaling in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

Membrane tumor necrosis factor confers partial protection to Listeria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.3A0515-207R

21 January 2018

Identifiers

DOI

10.1189/JLB.3A0515-207R

1 reference

24 September 2017

1 reference